Nikola Kotur

633 total citations
42 papers, 453 citations indexed

About

Nikola Kotur is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Molecular Biology. According to data from OpenAlex, Nikola Kotur has authored 42 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Nikola Kotur's work include Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Inflammatory Bowel Disease (6 papers). Nikola Kotur is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Inflammatory Bowel Disease (6 papers). Nikola Kotur collaborates with scholars based in Serbia, Russia and Italy. Nikola Kotur's co-authors include Sonja Pavlović, Biljana Stanković, Branka Zukić, Lidija Dokmanović, Dragana Janić, Sanja Dragašević, Tamara Alempijević, Dragan Popović, Jelena Lazić and Gordana Nikčević and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Current Medicinal Chemistry.

In The Last Decade

Nikola Kotur

39 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikola Kotur Serbia 16 119 102 94 87 73 42 453
S. Vishnupriya India 16 267 2.2× 95 0.9× 74 0.8× 65 0.7× 35 0.5× 50 612
Katie J. Lee Australia 16 140 1.2× 29 0.3× 69 0.7× 85 1.0× 120 1.6× 33 666
Martina Girardelli Italy 13 357 3.0× 123 1.2× 38 0.4× 80 0.9× 39 0.5× 30 677
Suhua Chen China 15 168 1.4× 20 0.2× 117 1.2× 88 1.0× 207 2.8× 53 694
Mohamed Egypt 13 102 0.9× 32 0.3× 39 0.4× 200 2.3× 28 0.4× 58 604
Ayako Kobori Japan 7 91 0.8× 144 1.4× 55 0.6× 62 0.7× 21 0.3× 9 479
Tricia Finney‐Hayward United States 11 112 0.9× 153 1.5× 17 0.2× 177 2.0× 38 0.5× 25 661
Mona Høysæter Fenstad Norway 11 111 0.9× 28 0.3× 149 1.6× 38 0.4× 241 3.3× 21 661
Yin Ping Wong Malaysia 12 155 1.3× 17 0.2× 73 0.8× 146 1.7× 89 1.2× 57 599
Anna Reznichenko Sweden 10 160 1.3× 117 1.1× 26 0.3× 46 0.5× 37 0.5× 18 445

Countries citing papers authored by Nikola Kotur

Since Specialization
Citations

This map shows the geographic impact of Nikola Kotur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikola Kotur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikola Kotur more than expected).

Fields of papers citing papers by Nikola Kotur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikola Kotur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikola Kotur. The network helps show where Nikola Kotur may publish in the future.

Co-authorship network of co-authors of Nikola Kotur

This figure shows the co-authorship network connecting the top 25 collaborators of Nikola Kotur. A scholar is included among the top collaborators of Nikola Kotur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikola Kotur. Nikola Kotur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bramuzzo, Matteo, Erika Cecchin, Biljana Stanković, et al.. (2025). NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease. Biomedicine & Pharmacotherapy. 183. 117824–117824. 1 indexed citations
2.
Tos̆ić, Nataša, Vojin Vuković, Nikola Kotur, et al.. (2025). High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 26(3). 1153–1153.
3.
Pavlovic, Djordje, et al.. (2025). Comprehensive pharmacogenomics profiling of the Serbian population. Frontiers in Pharmacology. 16. 1553536–1553536.
4.
Dragašević, Sanja, Biljana Stanković, Nikola Kotur, et al.. (2024). Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation. Inflammatory Bowel Diseases. 31(6). 1567–1573. 3 indexed citations
5.
Kotur, Nikola, Biljana Stanković, & Sonja Pavlović. (2023). Micronutrients, genetics and COVID-19. Current Opinion in Clinical Nutrition & Metabolic Care. 26(4). 309–315. 1 indexed citations
6.
Alagić, Sladjana, et al.. (2021). Cytotoxicity of the gold complex based on mercaptotriazole – A comparison with the conventional cyanide electrolyte. Journal of the Indian Chemical Society. 98(11). 100219–100219. 2 indexed citations
7.
8.
9.
Stanković, Biljana, et al.. (2020). Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations. Journal of Medical Biochemistry. 39(4). 488–499. 6 indexed citations
10.
Kotur, Nikola, Jelena Lazić, Biljana Stanković, et al.. (2020). Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment. Genes. 11(4). 468–468. 19 indexed citations
11.
Stanković, Biljana, et al.. (2020). Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection. Infection Genetics and Evolution. 84. 104498–104498. 19 indexed citations
12.
Stanković, Biljana, Sanja Dragašević, Nikola Kotur, et al.. (2020). Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy. Pathology - Research and Practice. 216(6). 152945–152945. 3 indexed citations
13.
14.
Zukić, Branka, Lidija Dokmanović, Marianna Lucafò, et al.. (2019). Expression pattern of long non-coding RNA growth arrest-specific 5 in the remission induction therapy in childhood acute lymphoblastic leukemia. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Kotur, Nikola, Jelena Lazić, Biljana Stanković, et al.. (2019). Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemia.. PubMed. 24(5). 2075–2083. 3 indexed citations
16.
Zukić, Branka, Biljana Stanković, Dragana Janić, et al.. (2018). Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radiology and Oncology. 52(3). 296–306. 16 indexed citations
17.
Vuković, Mira, Nedeljko Radlović, Zoran Leković, et al.. (2018). UGT1A1 (TA) n promoter genotype: Diagnostic and population pharmacogenetic marker in Serbia. Balkan Journal of Medical Genetics. 21(1). 59–68. 6 indexed citations
18.
Stanković, Biljana, Branka Zukić, Dragana Janić, et al.. (2018). Expression pattern of long non-coding RNA growth arrest-specific 5 in the remission induction therapy in childhood acute lymphoblastic leukemia. Journal of Medical Biochemistry. 38(3). 292–298. 24 indexed citations
19.
Aradski, Ana Alimpić, Nikola Kotur, Biljana Stanković, et al.. (2014). The in vitro antioxidative and cytotoxic effects of selected Salvia species water extracts. SHILAP Revista de lepidopterología. 12 indexed citations
20.
Kotur, Nikola, Biljana Stanković, Marianthi Georgitsi, et al.. (2012). 6-Mercaptopurine influences TPMT gene Transcription in a TPMT Gene Promoter Variable Number of Tandem Repeats-Dependent Manner. Pharmacogenomics. 13(3). 283–295. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Vishnupriya Breakdown of academic impact, for papers by Katie J. Lee Breakdown of academic impact, for papers by Martina Girardelli Breakdown of academic impact, for papers by Suhua Chen Breakdown of academic impact, for papers by Mohamed Breakdown of academic impact, for papers by Ayako Kobori Breakdown of academic impact, for papers by Tricia Finney‐Hayward Breakdown of academic impact, for papers by Mona Høysæter Fenstad Breakdown of academic impact, for papers by Yin Ping Wong Breakdown of academic impact, for papers by Anna Reznichenko
Rankless by CCL
2026